Sunitinib shrinks NET-G3 pancreatic neuroendocrine neoplasms

ConclusionOur results indicate that sunitinib is as effective for NET-G3 as for NET-G1/2.

Source: Journal of Cancer Research and Clinical Oncology - May 12, 2018 Category: Cancer & Oncology Source Type: research